SAT0227 Two-Year Retention and Effectiveness of IV Abatacept Monotherapy and Combination in PTS with RA Previously Treated with at Least One Biologic Agent in A Real-Life Setting: Subgroup Analysis from the Action Study

Abstract

BackgroundAlthough biologic agents should be preferentially used in combination with MTX or other conventional synthetic (cs)DMARDs,1 monotherapy with a biologic may be considered, especially if there is an intolerance to...